Dr. Aseel Walker, MD
Claim this profileHartford Hospital
Studies Aortic Disease
Studies Aortic Aneurysm
4 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Aseel Walker, MD is currently running
Liposomal Bupivacaine
for Bowel Surgery Pain Management
This study will be a single center, prospective triple blinded randomized controlled study, comparing the use of liposomal bupivacaine (Exparel) to regular bupivacaine with adjuncts in bilateral mid-abdominal transverse abdominis plane (TAP) blocks for patients undergoing laparoscopic colectomy procedures.
Recruiting3 awards Phase 4
Bupivacaine, Liposomal Bupivacaine, and Ropivacaine
for Aortic Disease
The goal of this randomized clinical trial is to compare single shot rectus sheath blocks of liposomal bupivacaine/bupivacaine mixture to bilateral rectus sheath catheters infused with ropivacaine (standard of care at our facility) in patients undergoing vascular surgery with an open mid-abdominal laparotomy incision. This study will examine the difference in the highest, lowest, average, and current pain scores reported at the end of 24-48 postoperative hours using the brief pain inventory-short form (BPI-SF). Participants will be randomized to either receive a single dose of liposomal bupivacaine/bupivacaine mixture intraoperatively at the end of surgery through bilateral rectus sheath blocks (LB/B group) or to receive the standard of care ropivacaine intraoperatively at the end of surgery through bilateral rectus sheath blocks with the insertion of bilateral RS catheter for continuous ropivacaine infusion plus repeated daily boluses (Catheter group; standard care). They will be assessed for a difference in postoperative pain scores, opioid consumption, hospital and PACU length of stay, patient's satisfaction, and quality of recovery. Additionally, we will examine the resources consumed by each intervention, including the medication cost (ropivacaine vs. LB/bupivacaine mixture), block and catheter supply, hospital length of stay, and anesthesia billing time.
Recruiting3 awards Phase 45 criteria
More about Aseel Walker, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Aseel Walker, MD has experience with
- Bupivacaine
- Liposomal Bupivacaine
- Ropivacaine
- Bupivacaine HCL
- Liposomal Bupivicaine/Bupivacaine Admixture
- Etomidate
Breakdown of trials Aseel Walker, MD has run
Abdominal Aortic Aneurysm
Aortoiliac Occlusive Disease
Bowel Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aseel Walker, MD specialize in?
Aseel Walker, MD focuses on Aortic Disease and Aortic Aneurysm. In particular, much of their work with Aortic Disease has involved treating patients, or patients who are undergoing treatment.
Is Aseel Walker, MD currently recruiting for clinical trials?
Yes, Aseel Walker, MD is currently recruiting for 4 clinical trials in Hartford Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Aseel Walker, MD has studied deeply?
Yes, Aseel Walker, MD has studied treatments such as Bupivacaine, Liposomal Bupivacaine, Ropivacaine.
What is the best way to schedule an appointment with Aseel Walker, MD?
Apply for one of the trials that Aseel Walker, MD is conducting.
What is the office address of Aseel Walker, MD?
The office of Aseel Walker, MD is located at: Hartford Hospital, Hartford, Connecticut 06102 United States. This is the address for their practice at the Hartford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.